New User:

Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 28, 2013
10:42 EDTCTXSCitrix Systems shares should be bought into Q4 results, says MKM Partners
MKM Partners expects Citrix's Q4 results to be seasonally strong, and the firm expects the stock to have positive momentum following the results. It expects the company's FY13 guidance to be at least in-line and maintains a Buy rating.
News For CTXS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 25, 2015
11:43 EDTCTXSCitrix may not be for sale according to internal memo, Fortune reports
Subscribe for More Information
September 23, 2015
09:09 EDTCTXSOn The Fly: Pre-market Movers
HIGHER: Heron Therapeutics (HRTX), up 20% after announcing results from its Phase 2 clinical study of its drug for the management of post-operative pain in patients undergoing bunionectomy... BioMed Realty Trust (BMR), up 10% after Bloomberg reported that the company is in talks to sell itself and has attracted interest from companies including Blackstone (BX) and Canaccord upgraded BioMed Realty to Buy... Citrix Systems (CTXS), up 2.5% after Reuters said the company is making a last-ditch attempt to sell itself as a whole company before beginning asset sales. LOWER: OncoGenex (OGXI), down 19% after the company reported that the addition of apatorsen to Abraxane and gemcitabine did not demonstrate a survival benefit compared to Abraxane and gemcitabine alone in a Phase 2 clinical study... Pacira Pharmaceuticals (PCRX), down 3.7% in the wake of Heron's new data, with several analysts stating that Heron's data compares favorably versus Pacira's Exparel drug.
05:59 EDTCTXSCitrix again tries to sell itself, Reuters reports
Subscribe for More Information
September 22, 2015
08:04 EDTCTXSCitrix says Royal Caribbean deploys mobile workspace solution
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the disclaimer & terms of use